Pre-made Dorlimomab Aritox benchmark antibody (ADC, anti-40S ribosomal protein S18 therapeutic antibody) for drug discovery and mechanism of action (MOA) research
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
Product Details
Pre-made Dorlimomab Aritox benchmark antibody (ADC, anti-40S ribosomal protein S18 therapeutic antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
| Products Name (INN Index) | Pre-Made Dorlimomab Aritox Biosimilar, Whole Mab Adc: Anti-40S Ribosomal Protein S18 therapeutic antibody |
|---|---|
| INN Name | dorlimomab aritox |
| Target | 40S ribosomal protein S18 |
| Format | ADC |
| Derivation | Mus musculus |
| Species Reactivity | Human |
| CH1 Isotype | F(ab')2 – nd – nd |
| VD LC | F(ab')2 – nd – nd |
| Highest_Clin_Trial (Jan '20) | NA |
| Est. Status | NA |
| 100% SI Structure | NA |
| 99% SI Structure | NA |
| 95-98% SI Structure | NA |
| Year Proposed | NA |
| Year Recommended | NA |
| Companies | Medarex (Princeton NJ USA) / Houston Biotechnology (The Woodlands TX USA) |
| Conditions Approved | NA |
| Conditions Active | NA |
| Conditions Discontinued | NA |
| Development Tech | NA |
| Previous Name | NA |
| Gm Offical Target Name | 40S ribosomal protein S18 |
| Package |
